US Broker Ratings

BioLife Solutions (BLFS) Investor Outlook: Analyzing the 50% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS) stands as a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Bothell, Washington, this company is at..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring the 55.59% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) stands out in the biotechnology sector, particularly in the niche of developing treatments for retinal diseases and other ocular conditions. With a market capitalization of..

Wave Life Sciences Ltd. (WVE): Investor Outlook on a High-Potential Biotech Stock with 159% Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, is garnering significant attention from investors with its promising drug development platform and substantial potential upside. Operating within the healthcare..

Omnicell, Inc. (OMCL): Investor Outlook Reveals 56% Potential Upside

Omnicell, Inc. (NASDAQ: OMCL), a notable player in the healthcare sector, specifically within the health information services industry, presents an intriguing opportunity for investors seeking exposure to innovative medication management..

MannKind Corporation (MNKD) Stock Analysis: A Promising Biotech Play with 146.82% Potential Upside

For investors with an eye on the biotechnology sector, MannKind Corporation (NASDAQ: MNKD) presents a compelling opportunity. With a market capitalization of $1.16 billion, MannKind operates in the healthcare sector,..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a Potential 39.62% Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specializes in medical devices with a focus on surgical instruments, neurosurgical, and wound care products. As the..

Opko Health, Inc. (OPK): Investor Outlook and Potential Upside of 185%

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, operates within the diagnostics and research industry. With a market capitalization of $1.11 billion, Opko Health is carving..

Pacira BioSciences, Inc. (PCRX)

⚠️ No article content returned.

..

Disc Medicine, Inc. (IRON) Stock Analysis: Potential 63.78% Upside Captivates Investor Interest

Disc Medicine, Inc. (NASDAQ: IRON), a promising player in the biotechnology sector, is garnering significant attention from investors, distinguished by its robust market cap of $2.06 billion. With a focus..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 30.92% Upside Potential Beckons Investors

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector’s medical instruments and supplies industry, presents a compelling case for investors looking for growth opportunities. With a market..

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 56% Potential Upside Amid Healthcare’s Digital Evolution

Evolent Health, Inc. (NYSE: EVH), a prominent player in the health information services industry, is gaining attention from investors with a compelling potential upside of 56.05%. This figure emerges from..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 53% Upside Potential in the Thriving Eyecare Market

Harrow, Inc. (NASDAQ: HROW) stands out in the healthcare sector as a dynamic player specializing in ophthalmic pharmaceutical products. With a market capitalization of $1.36 billion, the Nashville-based company is..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a 97% Upside in Biotechnology

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is emerging as a compelling player in the biotechnology sector, capturing investor attention with an impressive potential upside of 97.38% based on current analyst ratings...

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Strong Buy Ratings Signal 77.76% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC) is emerging as a captivating opportunity for investors seeking exposure in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 52.9% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a notable player in the healthcare sector, specializing in the development, manufacturing, and marketing of generic and proprietary injectable, inhalation, and intranasal products. With..

Janux Therapeutics (JANX) Stock Analysis: Unveiling a 222% Upside Potential in the Biotech Sector

For investors with a keen eye on the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) presents a compelling opportunity. This San Diego-based company is making strides in the realm of..

Establishment Labs Holdings Inc (ESTA) Investor Outlook: Navigating a 27.93% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA) is a name that has been making waves in the medical device sector, particularly within the niche of aesthetic and reconstructive surgery solutions. With..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 40.71% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO) is positioning itself as a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Plymouth Meeting, Pennsylvania, the company has carved..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a Potential Upside of Nearly 78%

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, is dedicated to providing cutting-edge diagnostic and research services with a particular focus on cancer-related testing. Based in Fort..

Viridian Therapeutics, Inc. (VRDN): Analyst Consensus Reveals 128% Upside Potential

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is creating a buzz in the biotechnology sector with its focus on developing innovative treatments for serious and rare diseases. With its current pipeline, the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds